Andrew J. Last - 29 Apr 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, Chief Operating Officer
Signature: /s/ Andrew J. Last
Issuer symbol: BIO
Transactions as of: 29 Apr 2023
Net transactions value: -$155,973
Form type: 4
Filing time: 01 May 2023, 12:51:12 UTC
Previous filing: 07 Sep 2022
Next filing: 27 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+1,000	+32%	$0.000000	4,113	29 Apr 2023	Direct	F1, F2
transaction	BIO	Bio-Rad A Common Stock	Tax liability	$155,973	-346	-8.4%	$450.79	3,767	29 Apr 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-1,000	-50%	$0.000000	1,000	29 Apr 2023	Bio-Rad A Common Stock	1,000	$0.000000	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Includes 8.8470 and 20.7590 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022 and 03/31/2023, respectively.
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.